Helping Biotechnology companies succeedToday’s rapidly changing biotechnology industry is delivering new levels of health, prosperity and sustainability. But it is also facing unprecedented challenges. Ernst & Young’s Global Biotechnology Center brings together a worldwide team of professionals to help you achieve your potential - a team with deep technical experience in providing assurance, tax, transaction and advisory services. The Center works to anticipate market trends, identify the implications and develop points of view on relevant industry issues. Ultimately it enables us to help you meet your goals and compete more effectively. It’s how Ernst & Young makes a difference. Visit our Global Biotechnology site for Beyond Borders, and other insights that cover the global market. | Lessons from change: the life sciences industry How can you manage your company through the recession and position yourself for growth? After interviewing thousands of life sciences executives, we identified some overarching themes. From managing risks to improving capital allocation, we reveal the lessons that could mean the difference between surviving and thriving in the new economic environment. Beyond Borders: global biotechnology report 2008 The Ernst & Young 22nd annual report on the state of the biotechnology industry features critical insights about emerging trends. Biotech matures, medicine becomes more targeted, globalization accelerates and pharma restructures. How will these trends impact the industry? Key industry players and advisors set out to answer this question and more in a core group of articles. Request your copy of "Beyond Borders" today to gain critical insights into the emerging trends facing this industry. To download an electronic copy of the report, please click here (pdf, 4.2mb). Progressions 2008 - Executing for success: powering new business models L’enquête semestrielle « Progressions, Executing for success: powering new business models », conduite auprès de 40 dirigeants de 15 grands laboratoires pharmaceutiques dans le monde, identifie les risques et opportunités auxquelles l’industrie pharmaceutique fait face. Pour obtenir une version complète de notre rapport Progressions 2008, merci de contacter notre Equipe Pharma. |
| | |
EventsContacts Herman SchepersBiotechnology Leader Ernst & Young Tel: +32 2 774 91 11
| |
|
|
